MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects

Leukemia & Lymphoma
Wenlei ZhuoZhengtang Chen

Abstract

Evidence implicates MDM2 (murine double minute-2) T309G polymorphism as a risk factor for several cancers. Increasing numbers of studies have been carried out on the association of MDM2 T309G polymorphism with susceptibility to leukemia and have generated conflicting results. The aim of the present study was to derive a more precise estimation of the relationship. Meta-analyses assessing the association of MDM2 T309G variation with leukemia were conducted. Separate analyses on ethnicity and clinical types were also performed. Eligible studies were identified for the period up to February 2012. Consequently, seven publications including eight case-control studies with 1777 cases and 5482 controls were selected for analysis. The overall data indicated a significant association of the MDM2 T309G polymorphism with leukemia risk (GG vs. TT: odds ratio [OR] = 1.62; 95% confidence interval [CI] = 1.14-2.29; dominant model: OR = 1.20; 95% CI = 1.06-1.36; recessive model: OR = 1.47; 95% CI = 1.07-2.03). In subgroup analysis by ethnicity, the G allele may increase leukemia susceptibility among Asians (GG vs. TT: OR = 3.06; 95% CI = 2.05-4.56; dominant model: OR = 1.82; 95% CI = 1.31-2.51; recessive model: OR = 2.32; 95% CI = 1.69-3.19) b...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Nov 30, 2004·Statistics in Medicine·Ammarin ThakkinstianJohn Attia
Dec 2, 2004·Psychiatry Research·Marcus R MunafòJonathan Flint
May 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zheng Ye, Honglin Song
Mar 6, 2007·Best Practice & Research. Clinical Haematology·Stuart C Finch
May 15, 2007·The International Journal of Biochemistry & Cell Biology·Franck Toledo, Geoffrey M Wahl
Nov 6, 2007·Cancer Genetics and Cytogenetics·Onoshua LahiriMelanie Howell
Mar 4, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Beng Hooi PhangKanaga Sabapathy
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irina GryshchenkoInge Tinhofer
Jul 24, 2008·Journal of the National Cancer Institute. Monographs·Julie A Ross
Oct 24, 2008·American Journal of Epidemiology·Neela GuhaPatricia A Buffler
Jul 11, 2009·Breast Cancer Research and Treatment·Konstantinos P Economopoulos, Theodoros N Sergentanis
Aug 28, 2009·Leukemia Research·Thorsten ZenzStephan Stilgenbauer
May 25, 2010·European Journal of Haematology·Kerstin WillanderMats Linderholm
Jun 12, 2010·Leukemia Research·Charles G Mullighan
Jul 20, 2010·Nature Structural & Molecular Biology·Masha V PoyurovskyCarol Prives
Mar 4, 2011·Pediatric Blood & Cancer·Stephen P HungerCharles G Mullighan
Apr 16, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christina A ClarkeEllen T Chang
May 14, 2011·Archives of Medical Research·Guo-Yuan LiuLong Yu
May 19, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ryan M SwinneyGail E Tomlinson
Jul 21, 2011·DNA and Cell Biology·Xiangming CaoTao Zhao
Dec 7, 2011·American Journal of Epidemiology·Elizabeth MilneBruce K Armstrong

❮ Previous
Next ❯

Citations

Aug 28, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianfei TangChangqing Zhang
Jan 1, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qi-Wen ChenZhi-Qiang Meng
May 23, 2014·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·B ChenX-L Meng
Feb 18, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xianlu ZhuoQi Zhou
Mar 20, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Simon Blechman ZeichnerRobert John Poppiti

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.